


Ninsun Biotech
Biotechnology Research • Route de l'ile-au-Bois, Monthey, Switzerland • 1-10 Employees
Company overview
| Headquarters | Route de l'ile-au-Bois, Monthey, Switzerland |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at Ninsun Biotech
Vincent Carre
Cofounder Ninsun Biotech
About Ninsun Biotech
Ninsun Biotech is a start-up based in Valais at BioArk. It operates in the field of oncology and is revolutionising the marking of cancer stem cells by offering, for the first time, a specific biomarker for several cancers, including lung, breast and colon. Current technologies rely on the use of a combination of non-specific markers, so Ninsun Biotech is breaking new ground with its patented technology, offering new prospects in terms of diagnosis, monitoring (companion tests) and, ultimately, individualised treatment for patients. Ninsun Biotech’s stem cell marking kits are also perfectly compatible with the current clinical chain of patient management.
Ninsun Biotech revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Ninsun Biotech has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Ninsun Biotech has never raised funding before.
Frequently asked questions
4.8
40,000 users



